tirzepatide ndc Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Ozempic maker Novo Nordisk sues

The decision to stop treatment should be individualized, considering factors such as achievement of weight loss goals, medication tolerability, financial constraints, insurance coverage changes, or personal preference

A well-formulated multivitamin for GLP-1 users can help fill nutritional gaps while supporting energy, immune health, and metabolism

The lipid benefits appear to be secondary effects related to weight loss, improved insulin sensitivity, and direct metabolic actions of the dual incretin pathway

Studies have shown that semaglutide treatment increases populations of Akkermansia muciniphila, a bacteria associated with healthy metabolic function, while decreasing overall microbial diversity